MC2 Therapeutics Appoints Trine Ahlgreen as New CEO
POSTED: May 27, 2025
Copenhagen, May 27th, 2025 – MC2 Therapeutics, a commercial-stage pharmaceutical company focused on topical therapies in inflammatory skin conditions, today announced the appointment of Trine Ahlgreen as Chief Executive Officer, marking ...
READ FULL ARTICLE >